Women with ADHD: expert consensus, not a prevalence study

This statement is cited across our pages on ADHD burnout, recovery, neurodivergent burnout, and rejection sensitivity. It is also a common source for broad claims about women and ADHD.

The paper deserves a note because “expert consensus” can sound more definitive than its method. Consensus is useful when a field needs practical guidance despite gaps. It is not the same as a systematic review, a representative survey, or a clinical trial. Readers should know which kind of authority they are being asked to trust.

The group wanted to improve recognition, referral, assessment, treatment, and multi-agency support for girls and women with ADHD across the lifespan. It asked how ADHD may be overlooked, what should prompt assessment, and how care should respond to changing demands and transitions.

The paper also aimed to move practice away from an image of ADHD centred on an overtly disruptive boy. That stereotype can obscure girls and women who are inattentive, internally restless, overwhelmed, or working hard to compensate.

The UK ADHD Partnership convened a multidisciplinary meeting in London in November 2018. Attendees included health and mental-health professionals, academics, educators, occupational specialists, service users, and ADHD charity workers.

The day began with preliminary findings from an ongoing review and epidemiological work. Participants then worked in groups on identification and assessment, interventions, and multi-agency liaison. Facilitators and note-takers captured the discussion. The whole group debated the proposals until consensus was reached, and all authors reviewed and approved the manuscript.

The article describes its evidence review as selective. It did not publish a systematic search, study-selection flow, formal quality appraisal, or evidence grade for each recommendation. It also generated no new participant dataset.

The group’s central message was that girls and women can have both inattentive and hyperactive-impulsive ADHD, but their difficulties may be less likely to trigger referral. Inattention can be read as daydreaming, low effort, disorganisation, or overwhelm. Hyperactivity may be experienced as inner restlessness rather than obvious disruption.

Gendered expectations can change how the same behaviour is interpreted. The paper cited vignette studies in which male names or pronouns increased referral or treatment judgments even when the behaviour described was otherwise the same. Anxiety, depression, eating difficulties, or emotional lability can draw attention while ADHD underneath remains unexamined.

Compensatory strategies can also make the external picture look more manageable than the effort and impairment beneath it. Demands may expose the gap later—during educational transitions, independent living, work, parenting, or other periods when the amount of organisation increases.

The group recommended assessment across settings and development, attention to functional and emotional impact, and coordination among health, education, and social systems. It also identified large research gaps, including hormonal transitions and treatment response across the lifespan.

Not how many girls or women are missed. The statement discusses differences between clinical and community ratios, but it does not conduct a prevalence study or calculate the undiagnosed population.

Not one female presentation. The paper describes tendencies and barriers. Women can be visibly hyperactive or disruptive; men can be inattentive, internalise distress, or compensate. Group patterns are not individual rules.

Not a systematic evidence grade. Recommendations combine published research, clinical experience, service-user perspective, and consensus. The article does not show which element carried each recommendation or formally rate certainty.

Not settled hormone evidence. Menstrual, pregnancy, postpartum, and menopausal changes are named as clinically important and under-researched. The authors explicitly call for more work on hormones, symptoms, and medication.

Not independent of funding context. The meeting was funded by the UK ADHD Partnership, which had received an unrestricted educational donation from Takeda. The paper states that Takeda had no role in the topic, meeting, consensus, or manuscript. Several authors also disclosed industry honoraria or private-practice affiliations.

The statement’s best contribution is a change in the threshold for curiosity. A person should not have to be disruptive before someone asks whether attention regulation and impulsivity are making life harder. Looking across a developmental history, private cost, and changing demands can reveal what one classroom or appointment misses.

Its practical authority comes from convergence: multiple professions, service-user representation, and an evidence base brought into one room. Its evidentiary limit comes from the same place. Consensus can organise experience and guide decisions; it cannot turn a thin literature into a precise effect estimate.

The right use is to widen assessment and support. The wrong use is to replace one stereotype with another—the quiet, anxious, masking woman who must fit every feature on a new list.

The paper reflects a UK-centred professional and service context, informed by international studies. It includes service users and charity workers but is not a participatory study of a recruited group of women with ADHD.

Its male/female framing gives limited attention to trans and non-binary people or to the way race, class, culture, disability, and access shape who gets referred. The consensus acknowledges research gaps but cannot fill them.

The field needs updated systematic reviews that report sex and gender separately where the data allow, and large studies that start from communities rather than clinics. Referral experiments can test which stereotypes change decisions. Longitudinal work can show when compensation stops being enough and which supports prevent a crisis from becoming the first route to recognition.

Hormonal transitions need prospective research rather than retrospective certainty. Studies should track symptoms, sleep, mood, medication, cycle or transition stage, and daily functioning while preserving individual variation and informed clinical choice.